Literature DB >> 26088635

Favipiravir--a prophylactic treatment for Ebola contacts?

Michel Van Herp1, Hilde Declerck2, Tom Decroo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26088635     DOI： 10.1016/S0140-6736(15)61095-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.

Authors:  Pierangelo Chinello; Nicola Petrosillo; Silvia Pittalis; Gianluigi Biava; Giuseppe Ippolito; Emanuele Nicastri
Journal:  PLoS Negl Trop Dis       Date:  2017-12-28

3.  Operational Research during the Ebola Emergency.

Authors:  Gabriel Fitzpatrick; Tom Decroo; Bertrand Draguez; Rosa Crestani; Axelle Ronsse; Rafael Van den Bergh; Michel Van Herp
Journal:  Emerg Infect Dis       Date:  2017-07       Impact factor: 6.883

4.  Occupational Exposures to Ebola Virus in Ebola Treatment Center, Conakry, Guinea.

Authors:  Hélène Savini; Frédéric Janvier; Ludovic Karkowski; Magali Billhot; Marc Aletti; Julien Bordes; Fassou Koulibaly; Pierre-Yves Cordier; Jean-Marie Cournac; Nancy Maugey; Nicolas Gagnon; Jean Cotte; Audrey Cambon; Christine Mac Nab; Sophie Moroge; Claire Rousseau; Vincent Foissaud; Thierry De Greslan; Hervé Granier; Gilles Cellarier; Eric Valade; Philippe Kraemer; Philippe Alla; Audrey Mérens; Emmanuel Sagui; Thierry Carmoi; Christophe Rapp
Journal:  Emerg Infect Dis       Date:  2017-08       Impact factor: 6.883

Review 5.  Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.

Authors:  Kuldeep Dhama; Kumaragurubaran Karthik; Rekha Khandia; Sandip Chakraborty; Ashok Munjal; Shyma K Latheef; Deepak Kumar; Muthannan Andavar Ramakrishnan; Yashpal Singh Malik; Rajendra Singh; Satya Veer Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.